Drug intelligence / Profile preview

DYN-Q6

Development stage: Preclinical
Lead developer: Dynomics
Modality: AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies, Gene Silencing → Gene Therapies, Gene Editing → Gene Therapies
Administration: Injection

Overview

DYN-Q6 is an investigational adeno-associated virus (AAV) gene therapy being developed by Dynomics for the treatment of cardiomyopathies. It utilizes the company's proprietary AJuV (Adeno-associated Virus for Unmet Cardiovascular needs) platform, which is specifically engineered to optimize gene transfer efficiency and expression within cardiovascular tissues. As the lead program in Dynomics' pipeline, DYN-Q6 is designed to deliver therapeutic genetic material to cardiac cells to address the underlying drivers of heart muscle disease. While the specific therapeutic transgene has not been publicly disclosed, the program aims to provide a targeted treatment option for patients with unmet needs in the management of cardiomyopathies.

Other names: AJuV Gene Therapy for Cardiomyopathies

Beyond the preview

Go deeper on DYN-Q6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DYN-Q6.

Explore the full profile